News

GEN - Genetic Engineering and Biotechnology News1h
StockWatch: Sarepta Says Deaths of Two Elevidys Patients Posted on FDA Database Unrelated to Treatment
Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...
Asianet Newsable on MSN1h
Trump Ally Laura Loomer Calls Vinay Prasad A ‘Marxist Trojan Horse’ After FDA Rehiring, Slams NASA For Dropping Isaacman
Prasad resigned from the FDA in July after backlash over his handling of Sarepta’s Elevidys gene therapy, which faced ...
TipRanks on MSN10h
Sarepta price target raised to $14 from $12 at Citi
Citi raised the firm’s price target on Sarepta (SRPT) to $14 from $12 and keeps a Sell rating on the shares. The company’s Q2 sales beat estimates ...
Wall Street Brunch: CPI With A Twist Due
The July CPI is expected to show a rise in annual retail inflation. AMC and Cisco among those reporting earnings. Nvidia ...
Sarepta Therapeutics (SRPT) Receives a Sell from Citi
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.